My bookmarksSign up free

Commission Implementing Regulation (EU) 2020/43 of 17 January 2020 amending Regulation (EU) No 37/2010 to classify the substance ciclesonide as regards its maximum residue limit (Text with EEA relevance)

Commission Implementing Regulation (EU) 2020/43 of 17 January 2020 amending Regulation (EU) No 37/2010 to classify the substance ciclesonide as regards its maximum residue limit (Text with EEA relevance)

Implementing Regulation (EU) 2020/43 Β· Regulation Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification β€˜Ciclesonide The sum of ciclesonide and desisobutyryl-ciclesonide, measured as desisobutyryl-ciclesonide after hydrolysis of ciclesonide to desisobutyryl-ciclesonide Equidae 0,6 ΞΌg/kg 4 ΞΌg/kg 0,6 ΞΌg/kg 0,6 ΞΌg/kg Muscle Fat Liver Kidney Not for use in animals from which milk is produced for human consumption Corticoides/Glucocorticoides’

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next